Personalis to Report First Quarter 2021 Financial Results on May 5, 2021

Rhea-AI Summary

Personalis, Inc. (Nasdaq: PSNL) will announce its Q1 2021 financial results on May 5, 2021, after market close. The company will host a conference call and webcast at 2:00 p.m. PT / 5:00 p.m. ET to discuss these results and provide recent highlights. Interested participants can join the live call via phone or through the company's website. Personalis specializes in advanced genomics for cancer, serving as a key sequencing provider for major initiatives like the U.S. Department of Veterans Affairs Million Veterans Program.

Positive

• Personalis is a leader in population sequencing and cancer genomics.
• The company is the sole sequencing provider for the U.S. Department of Veterans Affairs Million Veterans Program.
• Personalis provides comprehensive molecular data to biopharmaceutical customers through the ImmunoID NeXT Platform.

Negative

• None.

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, announced today it will release its first quarter 2021 financial results after the market closes on Wednesday, May 5, 2021. In conjunction with the release, the Company will host a conference call and webcast that day at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time to discuss its financial results and recent highlights.

Interested parties may access the live call via telephone by dialing (866) 220-8061 for domestic callers or (470) 495-9168 for international callers, using conference ID: 6587766. The live webinar of the call may be accessed by visiting the Events section of the company's website at investors.personalis.com. A replay of the webinar will be available shortly after the conclusion of the call and will be archived on the company's website.

About Personalis, Inc.

Personalis, Inc. is a leader in population sequencing and cancer genomics, with a focus on data, scale, efficiency and quality. Personalis operates one of the largest sequencing programs globally and is currently the sole sequencing provider to the U.S. Department of Veterans Affairs Million Veterans Program. In oncology, Personalis is transforming the development of next-generation therapies by providing more comprehensive molecular data about each patient’s cancer and immune response. The Personalis^® ImmunoID NeXT Platform^® is designed to adapt to the complex and evolving understanding of cancer, providing its biopharmaceutical customers with information on all of the approximately 20,000 human genes, together with the immune system, from a single tissue or blood sample. The Personalis^® Clinical Laboratory is GxP aligned as well as CLIA’88-certified and CAP-accredited.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210421005028/en/

FAQ

When will Personalis release its Q1 2021 financial results?

Personalis will release its Q1 2021 financial results on May 5, 2021, after market closing.

What time is the Personalis conference call for Q1 2021 results?

The conference call is scheduled for May 5, 2021, at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time.

How can I access the Personalis conference call?

You can access the call by dialing (866) 220-8061 for domestic calls or (470) 495-9168 for international calls, using conference ID: 6587766. It will also be available via webcast on their website.

What is Personalis known for?

Personalis is known for its advanced genomics services, particularly in cancer sequencing and being a key provider for the Million Veterans Program.